About this Webinar: Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the past few years have created unprecedented opportunities to better identify biomarkers of disease processes, especially by using...
.
Using Artificial Intelligence to support Quantitative Digital Pathology in R&D
About this Webinar: This session, 'Using Artificial Intelligence (AI) to support Quantitative Digital Pathology in R&D', was live on Wednesday 17th November 2021. You can re-watch the full webinar including the Q&A above. Presented by OracleBio's Chief...
Conducting Quantitative Image Analysis to Good Clinical Practice (GCP)
Good clinical practice (GCP) is an internationally recognised ethical and scientific standard for designing, recording and reporting trials that involve the participation of human subjects. For quantitative image analysis data to be included in a data package...
From Images to Data: Outsourcing Quantitative Digital Pathology
OracleBio is a global leader in quantitative digital pathology services to Pharma and Biotech clients worldwide. Leveraging industry-leading image analysis software platforms, the company delivers robust data packages to support clinical trials and translational...
Gaining Key Phenotypic Data From the Tumor Microenvironment Using 8-plex Immunofluorescence Staining and Image Analysis
Angela Vasaturo, PhD; Senior Scientist, Ultivue Lorcan Sherry, PhD; Chief Science Officer, OracleBio Broadcast via The Pathologist, November 2020 Multiplex staining and image analysis are being increasingly deployed for immuno-oncology (I/O) evaluations to investigate...